Ag industry’s failure to communicate biotech’s benefits to blame for heated GMO debate

The heated public debate over genetically modified foods shows the agricultural industry is not doing enough to communicate biotechnology’s benefits to society, according to a group of witnesses hosted by the House Agriculture Subcommittee Horticulture, Research, Biotechnology, and Foreign Agriculture on Wednesday.

“Today’s hearing made it very clear that we still have a lot of work to do to communicate with the public about the benefits of biotech,” said Ranking Member Kurt Schrader, D-Oregon.

David Just of Cornell University said there is a tide of “irrational consumer fears” regarding biotechnology. The science of biotechnology is vast and includes hybrid genetic engineering as well as trangenics, or GMOs.

Additionally, Calestous Juma of the Harvard Kennedy School of Government, said political leadership is hesitant to make changes in support of biotechnology, which is “something they think their voters might not support.”

He said, “Biotechnology product pipelines are being choked by discriminatory regulations, labeling threats, and a rising tide of product disparagement and misinformation.”

Industry members have acknowledged a lack of initiative to communicate with the public over the past couple of decades. The Council for Biotechnology Information, which includes BASF, Bayer CropScience, Dow AgroSciences, DuPont, Monsanto Company and Syngenta, recently formed the GMO Answers campaign and website in an attempt to conduct a forum that could address the public’s concerns about biotechnology.

Read the full, original article: Lack of communication is to blame in biotech debate, according to House panel

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
Screenshot-2026-05-21-at-3.15.53-PM
Chiropractors may no longer be modern-day snake oil salesmen, but the benefits of their therapy are limited–at best

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.